Question Bank › Operator fluency on fresh ground

Operator fluency on fresh ground

Operator fluency on fresh ground: management answers probing questions about a new driver with unhesitating operational

Calls Tested
499
Answered YES
40
Hit Rate
8%
rare by design

Nanobiotix S.A. (NBTX) — this company's answers

NO on the Q2 2023 call 2023-09-27 D
The model's full reasoning — Q2 2023 call → NOWe need to determine if the transcript shows the dynamic described: a recently emerged positive element, probed by analysts, and management responds with unhesitating, granular operational command across at least two exchanges, conveying that the element's contribution is still early. The recently emerged positive element: The Janssen partnership. It was signed recently (first half 2023). Analysts probe it. Specifically, Lucy Codrington asks about "payment in kind support for 312" and "IO combination, Phase 3 and beyond" regarding J&J's commitment. Also another analyst asks about Hensify in soft tissue sarcoma and LianBio. But the question is about a "recently emerged positive element" that is "real and current" and "young" - new to meaningful contribution within recent quarters. The Janssen deal is indeed recent. Management responds to questions about it. However, does management provide granular operational detail? Let's examine. Lucy asks: "in terms of the payment in kind support for 312, when can we expect that to begin from J&J?" Laurent responds: "we've been initiating this contract in July, became effective in August and since then we've been working a lot with the Johnson & Johnson team to start putting everything into motion and that includes the treat well and the potential help they will bring in helping us across different countries. So we are finalizing the plan as we speak. So we have no specific to deliver to the market for now, but be reassured that we are pretty active in that aspect of the program." That is somewhat general, not granular operational detail like specific numbers, timelines, or how it's being produced. It's more of a status update. Then Lucy asks about IO combination Phase 3 and J&J's commitment. Laurent says they are reviewing what's best, discussing with partner, may do something more powerful. That's not granular operational detail. Then another analyst asks about Hensify in soft tissue sarcoma and LianBio. Laurent says it was part of due diligence, but no specific story. For LianBio, he says they are discussing options, but no specifics. So management is not providing granular operational command. They are giving general updates and future plans.

← Back to the full NBTX analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, when analysts probe a RECENTLY EMERGED positive element of the business — something whose meaningful contribution began only within roughly the last few quarters — does management respond with UNHESITATING, GRANULAR OPERATIONAL COMMAND: answering follow-up questions about that new element with specific, present-tense working detail (how it is actually being produced, delivered, staffed, scheduled, priced, or scaled; which kinds of counterparties are taking it and how they behave; what the company is doing this month and next to serve it) of the kind only operators deep inside a functioning activity could supply — while conveying that the element's contribution to the reported results is still early? Answer YES when the transcript shows this ONE dynamic, in whatever form fits the business: (1) the probed element is REAL AND CURRENT — actually transacting now, not a plan or pipeline; (2) it is YOUNG — new to meaningful contribution within recent quarters, per management's own framing; (3) management's answers across at least two exchanges ADD specific operational substance beyond the prepared remarks, without deflection, hedging into generalities, or retreat to talking points; and (4) management conveys, directly or plainly in substance, that most of the element's effect lies ahead of the reported numbers. Answer NO if the probed strength concerns the company's long-established core rather than something recently emerged. NO if management's answers repeat prepared points, answer specifics with generalities, or lean on vision and market size. NO if the added detail concerns only financial housekeeping (guidance arithmetic, tax, share count). NO if the element is already mature and substantially in the results. NO if the granular engagement occurs in only a single exchange. NO if the call lacks a substantive question-and-answer session. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
MCD McDonald's Corporation Q2 2024 2024-07-29 D
HCKT The Hackett Group, Inc. Q1 2024 2024-05-08 C
CTRA Coterra Energy Inc. Q1 2024 2024-05-03 A
ROCK Gibraltar Industries, Inc. Q1 2024 2024-05-01 B+
WEC WEC Energy Group, Inc. Q1 2024 2024-05-01 A
LTRX Lantronix, Inc. Q3 2024 2024-04-29 C
NICE NICE Ltd. Q4 2023 2024-02-22 B+
PUMP ProPetro Holding Corp. Q4 2023 2024-02-21 C+
EGP EastGroup Properties, Inc. Q4 2023 2024-02-08 B
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
FSBC Five Star Bancorp Q3 2023 2023-10-31 B
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
WGO Winnebago Industries, Inc. Q1 2023 2022-12-16 D
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
SYY Sysco Corporation Q1 2023 2022-11-01 C+
CHE Chemed Corporation Q3 2022 2022-11-01 B+
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
IRTC iRhythm Technologies, Inc. Q1 2022 2022-05-07 C+
ALHC Alignment Healthcare, Inc. Q3 2021 2021-11-06 B+
FFWM First Foundation Inc. Q3 2021 2021-10-26 B
KNDI Kandi Technologies Group, Inc. Q2 2021 2021-08-09 F
UMH UMH Properties, Inc. Q3 2018 2018-11-02 C+
AGIO Agios Pharmaceuticals, Inc. Q3 2018 2018-11-01 C
AMGN Amgen Inc. Q3 2018 2018-10-30 B+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
IRT Independence Realty Trust, Inc. Q2 2018 2018-08-02 B
KIM Kimco Realty Corporation Q2 2018 2018-07-26 B+
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
HLX Helix Energy Solutions Group, Inc. Q1 2018 2018-04-24 B+
TOUR Tuniu Corporation Q4 2017 2018-03-14 D
FI Fiserv, Inc. Q4 2017 2018-02-27 C
IR Ingersoll-Rand Plc Q3 2017 2017-10-25 B
GNTX Gentex Corporation Q3 2017 2017-10-20 B
BIIB Biogen Inc. Q2 2017 2017-07-25 B
AEHR Aehr Test Systems Q2 2017 2017-01-05 F
NDSN Nordson Corporation Q3 2016 2016-08-23 A
GOGO Gogo Inc. Q1 2016 2016-05-06 C+
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A
ENLC EnLink Midstream, LLC Q4 2015 2016-02-17 C+

How the model reasoned

IRT · Q2 2018 → YESThe question is about whether management shows unhesitating, granular operational command on a recently emerged positive element when analysts probe it. YES The transcript shows management providing unhesitating, granular operational detail on the value-add program—a recently emerged positive element whose meaningful contribution began within the last few quarters—as probed by analysts like John Massocca and Craig Kucera. They discuss specifics such as NOI growth from phase 1 rehabs in 4Q 18 (14-15% range), phase 2 as a slight drag, $4.
LTRX · Q3 2024 → YESThe question is about whether management shows unhesitating, granular operational command on a recently emerged positive element when analysts probe it.
NICE · Q4 2023 → YESThe question is about whether management shows unhesitating, granular operational command on a recently emerged positive element when analysts probe it.

More from the question bank

Demand has broadened across independent fronNew chapter with early proofSkeptical premise dismantled with receiptsProfit machinery upgraded while volume stillExternal validators convergingThe bottleneck is inside and being paid awayAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.